The Federal Register

Agency Forms Undergoing Paperwork Reduction Act Review

Wed, Nov 19 2003 11:00:00 GMT

The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 4981210. Send written comments to CDC, Desk Officer, Human Resources and Housing Branch, New Executive Office Building, Room 10235, Washington, DC 20503 or by fax to (202) 3956974. Written comments should be received within 30 days of this notice.

Proposed Project: Evaluation of the Process Required to Effectively Expand the National Laboratory System (NLS) to All StatesNewPublic Health Practice Program Office (PHPPO), Centers for Disease Control and Prevention (CDC).

In October 2000, the Centers for Disease Control and Prevention (CDC) and the Association of Public Health Laboratories (APHL) collaborated to support demonstration projects designed to test the feasibilit

Medicare Program: Review of National Coverage Determinations and Local Coverage Determinations

Wed, Nov 19 2003 11:00:00 GMT

Correction

In rule document 0327742 beginning on page 63692 in the issue of Friday, November 7, 2003, make the following corrections:

Sec. 426.410 [Corrected]

1. On page 63719, in the third column, under Sec. 426.410(a), the fifth line should read, ``(1) Dockets the complaint.''

2. On the same page, in the same column, in the same section, the sixth line should read, ``(2) Determines whether the complaint is.'' [FR Doc. C327742 Filed 111803; 8:45 am]
BILLING CODE 150501D

Statement of Organization, Functions, and Delegations of Authority for Regional Offices

Wed, Nov 19 2003 11:00:00 GMT

This Notice amends Part K of the Statement of Organization, Functions, and Delegations of Authority of the Department of Health and Human Services (HHS), Administration for Children and Families (ACF) as follows: Chapter KD, the Regional Offices of the Administration for Children and Families for: Region I, as last amended (61 FR 5002930) September 24, 1996; Region II, as last amended (61 FR 1814749) April 24, 1996, and (60 FR 2121112) May 1, 1995; Region III, as last amended (61 FR 68045) April 26, 1996; Region IV, as last amended (62 FR 15897 99) April 3, 1997; Region V, as last amended (65 FR 817374) February 17, 2000; Region VI, as last amended (61 FR 1814749) April 24, 1996, and (60 FR 2731516) May 23, 1995; Region VII, as last amended (61 FR 393738) February 2, 1996; Region VIII, as last amended (61 FR 52565 66) October 8, 1997; Region IX, as last amended (62 FR 3161011) June 10, 1997; and Region X, as last amended (61 FR 6804547) December 26, 1996.

This Notice reflects the eliminat

Implantation or Injectable Dosage Form New Animal Drugs; Dexamethasone Injection

Wed, Nov 19 2003 11:00:00 GMT

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Cross Vetpharm Group, Ltd. The ANADA provides for the veterinary prescription use of dexamethasone injectable solution in dogs, cats, cattle, and horses.

Food Labels, Packaging, Restaurants, and Weight Management; Public Workshop; Amendment of Notice

Wed, Nov 19 2003 11:00:00 GMT

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting entitled ``Food Labels, Packaging, Restaurants, and Weight Management; Public Workshop.'' The notice published in the Federal Register of October 17, 2003 (68 FR 59795). The amendment is being made to reflect that FDA is requesting comments regarding the workshop. There are no other changes.